AlphaHunt
Healthcare

ABBV Stock Analysis

AbbVie Inc. · current price $221.23 (-0.58% today)

★★★★ Quality 60/ Alpha Score
Solid setup — 3/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
LAST EARNINGS AbbVie Inc. (ABBV)

Latest earnings

EPS
$2.97 vs $2.91 est · +0.0% vs estimate BEAT
Revenue
$15.00B · -2.7% YoY
Stock reaction (1M)
+4.9%
Beat streak
3 of last 4 quarters

Key metrics

Alpha Score
60/100
Grade
B
Rev Growth YoY
+12.4%
30-day Momentum
+4.9%
Forward P/E
107.2×
Analyst Target
$253.55
Implied Upside
+14.6%

Latest news on ABBV

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA DGX

View all Healthcare stocks →

ABBV — frequently asked

What is ABBV's Alpha Score?

AbbVie Inc. (ABBV) currently has a TickerMover Alpha Score of 60/100, rated ★★★★ Quality. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is AbbVie Inc. (ABBV) a buy?

TickerMover does not give buy or sell recommendations. ABBV scores 60/100 (★★★★ Quality) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is ABBV's score updated?

ABBV's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for ABBV →
TickerMover is a research tool, not financial advice. Alpha Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.
Questions? support@tickermover.com